Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Marshall A. Schorin"'
Autor:
Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris, Kristen E. Stevenson, Andrew E. Place, Sarah K. Hunt, Jane E. O'Brien, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Maria Luisa Sulis, Jennifer J.G. Welch, Donna S. Neuberg, Stephen E. Sallan, Lewis B. Silverman
Publikováno v:
Blood Advances, Vol 2, Iss 12, Pp 1449-1458 (2018)
Abstract: Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocol 05-001 tested a new risk stratification system in children and adolescents with newly diagnosed acute lymphoblastic leukemia (ALL). At study entry, B-ALL patients were classified a
Externí odkaz:
https://doaj.org/article/7fe5b025a97248a2bd7140b86b897665
Autor:
Thai Hoa Tran, Marian H. Harris, Jonathan V. Nguyen, Traci M. Blonquist, Kristen E. Stevenson, Eileen Stonerock, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J.G. Welch, Shalini C. Reshmi, Donna S. Neuberg, Stephen E. Sallan, Mignon L. Loh, Lewis B. Silverman
Publikováno v:
Blood Advances, Vol 2, Iss 5, Pp 529-533 (2018)
Abstract: Recurrent chromosomal rearrangements carry prognostic significance in pediatric B-lineage acute lymphoblastic leukemia (B-ALL). Recent genome-wide analyses identified a high-risk B-ALL subtype characterized by a diverse spectrum of genetic
Externí odkaz:
https://doaj.org/article/44b885b31a124a5584f54b008afc7fdf
Autor:
Jean-Marie Leclerc, Uma H. Athale, Emily Schultz, Lewis B. Silverman, Elena J. Ladas, Stephen E. Sallan, Marian H. Harris, Song Yao, Caroline Laverdière, Justine M. Kahn, Kristen E. Stevenson, Qianqian Zhu, Peter D. Cole, Kara M. Kelly, Marshall A. Schorin, Luis A. Clavell, Jennifer J.G. Welch, Bruno Michon
Publikováno v:
Blood Adv
Hispanic children have a higher incidence of acute lymphoblastic leukemia (ALL) and inferior treatment outcomes relative to non-Hispanic White children. We previously reported that Hispanic children with ALL had lower risk of fracture and osteonecros
Autor:
Uma H. Athale, Stephen E. Sallan, Maneka Puligandla, Luis A. Clavell, Lewis B. Silverman, Elena J. Ladas, Kara M. Kelly, Manuela Orjuela, Caroline Laverdière, Jennifer J.G. Welch, Barbara L. Asselin, Kristen E. Stevenson, Bruno Michon, Traci M. Blonquist, Marshall A. Schorin, Jean-Marie Leclerc, Peter D. Cole
Publikováno v:
Journal of Clinical Oncology. 38:2151-2159
PURPOSE The benefits and risks of supplementation with antioxidants during cancer therapy have been a controversial area. Few studies have systematically evaluated dietary intake of antioxidants with toxicity and survival in childhood cancer. We soug
Autor:
Uma H. Athale, Yael Flamand, Traci Blonquist, Kristen E. Stevenson, Menachem Spira, Barbara L. Asselin, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean‐Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J.G. Welch, Marian H. Harris, Donna S. Neuberg, Stephen E. Sallan, Lewis B. Silverman
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(8)
Although thromboembolism (TE) is a serious complication in patients with acute lymphoblastic leukemia (ALL), thromboprophylaxis is not commonly used due to the inherent bleeding risk in this population. Identifying prothrombotic risk factors will hel
Autor:
Jennifer J.G. Welch, Luis A. Clavell, Sarah K. Hunt, Sarah M. Cronholm, Peter D. Cole, Kristen E. Stevenson, Jeffrey G. Supko, Bruno Michon, Donna Neuberg, Samantha Kay-Green, Kara M. Kelly, Jean-Marie Leclerc, Lynda M. Vrooman, Caroline Laverdière, Uma H. Athale, Traci M. Blonquist, Stephen E. Sallan, Marian H. Harris, Lewis B. Silverman, Victoria Koch, Andrew E. Place, Marshall A. Schorin
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(31)
PURPOSE Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia (ALL) Consortium Protocol 11-001 assessed efficacy and toxicity of calaspargase pegol (calaspargase), a novel pegylated asparaginase formulation with longer half-life, compared with th
Autor:
Sarah K. Hunt, Melissa A. Burns, Bruno Michon, Olga K. Weinberg, Uma H. Athale, Kristen E. Stevenson, Stephen E. Sallan, Suzanne J. Forrest, Lewis B. Silverman, Marian H. Harris, Jean-Marie Leclerc, Caroline Laverdière, Justine M. Kahn, Donna Neuberg, Barbara L. Asselin, Andrew E. Place, Yana Pikman, Kara M. Kelly, Marshall A. Schorin, Luis A. Clavell, Jennifer J.G. Welch, Maria Luisa Sulis, Lynda M. Vrooman, Jane E. O'Brien, Lisa M. Gennarini, Alejandro Gutierrez, Peter D. Cole
Publikováno v:
Pediatric Blood & Cancer. 68
Autor:
Justine M. Kahn, Jean-Marie Leclerc, Melissa A. Burns, Barbara L. Asselin, Sarah K. Hunt, Marshall A. Schorin, Donna Neuberg, Lisa M. Gennarini, Jennifer J.G. Welch, Alejandro Gutierrez, Andrew E. Place, Suzanne J. Forrest, Caroline Laverdière, Kara M. Kelly, Lynda M. Vrooman, Uma H. Athale, Bruno Michon, Jane E. O'Brien, Lewis B. Silverman, Marian H. Harris, Stephen E. Sallan, Peter D. Cole, Luis A. Clavell, Kristen E. Stevenson, Maria Luisa Sulis, Yana Pikman
Publikováno v:
Pediatr Blood Cancer
BACKGROUND/OBJECTIVES While outcomes for pediatric T-cell acute lymphoblastic leukemia (T-ALL) are favorable, there are few widely accepted prognostic factors, limiting the ability to risk stratify therapy. DESIGN/METHODS Dana-Farber Cancer Institute
Autor:
Andrew E. Place, Lewis B. Silverman, Barbara L. Asselin, Sarah K. Hunt, Peter D. Cole, Jean-Marie Leclerc, Bruno Michon, Jane E. O'Brien, Jennifer J.G. Welch, Marshall A. Schorin, Uma H. Athale, Stephen E. Sallan, Kristen E. Stevenson, Maria Luisa Sulis, Caroline Laverdière, Traci M. Blonquist, Lynda M. Vrooman, Luis A. Clavell, Donna Neuberg, Kara M. Kelly, Marian H. Harris
Publikováno v:
Blood Advances. 2:1449-1458
Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocol 05-001 tested a new risk stratification system in children and adolescents with newly diagnosed acute lymphoblastic leukemia (ALL). At study entry, B-ALL patients were classified as standard
Autor:
Marshall A. Schorin, Barbara L. Asselin, Peter D. Cole, Jean-Marie Leclerc, Traci M. Blonquist, Lewis B. Silverman, Steven E. Lipshultz, Kristen E. Stevenson, Marian H. Harris, Jennifer J.G. Welch, Jeffrey G. Supko, Andrew E. Place, Uma H. Athale, Sarah K. Hunt, Lynda M. Vrooman, Stephen E. Sallan, Luis A. Clavell, Jeffery L. Kutok, Caroline Laverdière, Jane E. O'Brien, Donna Neuberg, Kara M. Kelly, Bruno Michon
Publikováno v:
The Lancet Oncology. 16:1677-1690
Summary Background l-asparaginase is a universal component of treatment for childhood acute lymphoblastic leukaemia, and is usually administered intramuscularly. Pegylated Escherichia coli asparaginase (PEG-asparaginase) has a longer half-life and is